| IV-02 Anne-Gaelle Dosne Exposure-response analysis of erdafitinib and pharmacodynamic-guided dose individualization in patients with locally advanced or metastatic urothelial carcinoma Thursday 15:25-16:50 |
| IV-02 Anne-Gaelle Dosne Exposure-response analysis of erdafitinib and pharmacodynamic-guided dose individualization in patients with locally advanced or metastatic urothelial carcinoma Thursday 15:25-16:50 |